Health

The World’s First Malaria Drug For Babies Under 4.5kg, Coartem Baby Or Riamet Baby In Some Countries, Has Been Approved By Swiss Authorities. Developed By Novartis & MMV, It Will Be Rolled Out In Africa Soon. In 2023, Malaria Caused ~597K Deaths—76% Were Kids Under 5. This Not-For-Profit Drug Closes A Critical Care Gap For Newborn Babies.

…

For The First Time, Scientists In Scotland Beamed Light Through A Human Head Using Enhanced FNIRS By Boosting Laser Strength And Refining Photon Collection. Only 1 Of 8 Participants Showed Results, But It Proved A Breakthrough For Deeper, Affordable, & Portable Brain Scans—Potentially Revolutionizing Diagnosis For Strokes, Tumors, And More.

…

A New Blood Type, Gwada Negative, Was Found In A 68-Year-Old Woman From Guadeloupe. First Detected In 2011 In Paris, It Was Identified In 2019 Via Gene Sequencing As A Rare Pigz Gene Mutation. She’s The Only Known Match. It’s The 48th Blood Group; Only 8 Are Common. Blood Types Are Based On Antigens—The First, ABO, Was Discovered In 1901.

…

In 2023, A 19-Year-Old In China Became The Youngest Known Alzheimer’s (Alz) Case, With Memory Decline Starting At 17. MRI Showed Hippocampal Shrinkage And Alz’s Biomarkers. Unlike The Prior Youngest Case (@ 21, PSEN1 Mutation—Increased Amyloid-Beta), He Had No Family History Or Mutations, Suggesting New, Unknown Causes Of Early-Onset Alz’s.

…

The FDA Approved UCSF’s Adaptive Deep Brain Stimulation (aDBS), A Breakthrough Parkinson’s Treatment. Unlike Continuous DBS, aDBS Uses Real-Time Brain Signals To Target The Subthalamic Nucleus With Precise Electrical Pulses. It Offers Fast Mode (Instant PD Symptom Relief) And Slow Mode (Stabilization). AI-Driven aDBS For Wider PD Symptoms Is Anticipated.